Average cost of treatment during 8 years period after acute coronary syndrome depending on risk factors and comorbidities

Aim. The study shows average cost of treatment in 8 years after acute coronary sindrome (ACS), depending on risk factors, commorbidities and medical history. Matherials and methods. A retrospective cohort longterm study with a total of 613 patiens following ACS 2005- 2013. The mean treatment cost, undoubtedly associated and potentially with ACS associated costs were assessed, depending on sociodemographic factors, past coronary artery disease history, risk factors, commorbidities and ACS complications in 8 years period after ACS. Only cost of the treatment ad diagnostic methods was weighted. The SPSS version 13 was used for the statistical analysis, with a use of descriptive statistics, p level <0,05 considered significant. Results. The mean undoubtedly associated with ACS costs were 11847,83±10745,69 Lt (3431,37±3112,17 €), median 8169,20 Lt (2365,96 €), interquartile rank 11840,96 Lt (3429,38 €). Potentially associated with ACS costs were 1771±4766,05 Lt (512,92±1380,34 €), median 45,92 Lt (13,30 €), interquartile rank 1500 Lt (434,43 €). The significantly highest undoubtedly associated costs were found for people with hypertension and dyslipidaemia, for those with percutaneous coronary intervention or coronary by-pass treatment past history, o for those who were treated with invasive strategy in 8 years after ACS. Also the higher costs were in patients with major cardiovascular events in 8 years ater ACS (p<0,05). Renal failure (p<0,05) and stroke (p<0,001) were factors decreasing undoubtedly associated with ACS costs. Patients with heart failure, coronary by-pass past history, and experienced percutaneous coronary intervention or major cardiovascular event in 8 years after ACS have more higher potentially associated with ACS costs (p